UCLA Receives $2.2 Million to Support Technology Transfer

Funding will accelerate UCLA’s missions of translating research into societal benefit.

 

UCLA has received a $2.2 million boost in state funding that will help advance its innovation and entrepreneurship efforts.

The financial support comes from a $22 million investment in the University of California from Assembly Bill 2664, the Innovation and Entrepreneurship Expansion. It has been divided equally among the UC’s 10 campuses.

“This funding will truly accelerate UCLA’s fulfilling of one of its key missions: the translation of fundamental research to benefit society,” said Ann Karagozian, UCLA’s interim vice chancellor for research. “These funds will have a powerful impact on optimizing discoveries and inventions developed through our world-class UCLA research.”

Specifically, UCLA will direct much of its share toward helping turn grant-funded research into market-ready technology by demonstrating that ideas work as proofs of concept.

READ MORE

 

Trethera Corporation and Nanotherapeutics Sign Exclusive Worldwide Agreement

SANTA MONICA, Calif. & ALACHUA, Fla.–(BUSINESS WIRE)–Trethera Corporation and Nanotherapeutics, Inc. today announced the signing of an exclusive worldwide agreement whereby Nanotherapeutics has granted Trethera an exclusive license for the global development, manufacturing and marketing of Triapine® (3-AP) and all formulations, for the treatment of hematological malignancies. Triapine® is a clinical-stage, small molecule inhibitor of ribonucleotide reductase (RNR), a key enzyme in the de novo pathway of nucleotide biosynthesis.

READ MORE

UCLA Researchers Combat Antimicrobial Resistance Using Smartphones

A simple, inexpensive attachment could help to expand testing to regions with limited resources.

A team of UCLA researchers has developed an automated diagnostic test reader for antimicrobial resistance using a smartphone. The technology could lead to routine testing for antimicrobial susceptibility in areas with limited resources.

Antimicrobial-resistant bacteria are posing a severe threat to global public health. In particular, they are becoming more common in bacterial pathogens responsible for high-mortality diseases such as pneumonia, diarrhea and sepsis.

READ MORE